Streetbeat News

Earnings

LLY

Eli Lilly reported its Q2 2024 adjusted EPS of $3.92, significantly beating the estimate of $2.70. The company's sales also surpassed expectations, coming in at $11.303 billion compared to the estimated $9.949 billion.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:46 am

USFD

US Foods Holding Corp. (USFD) reported Q2 2024 adjusted EPS of $0.93, in line with expectations, and sales of $9.70 billion, beating the $9.64 billion estimate. The company also provided long-term guidance for 2024-2028, expecting 3%+ comparable sales growth, 5%+ net restaurant growth, 8%+ system-wide sales growth, and adjusted operating income growth at least as fast as system-wide sales growth.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:46 am

DNUT

Krispy Kreme (NASDAQ:DNUT) reported Q2 2024 adjusted earnings per share (EPS) of $0.05, meeting analyst expectations. The company also reported sales of $438.8 million, surpassing the $435.494 million estimate and marking a 7.32% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:45 am

WMS

Advanced Drainage Systems (NYSE:WMS) reported Q1 2025 earnings per share (EPS) of $2.06, missing the analyst consensus estimate of $2.07 by 0.48%. The company also reported quarterly sales of $815.336 million, which missed the estimate of $829.797 million by 1.74%. Despite the misses, sales increased by 4.79% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:43 am

PRVA

Privia Health has raised its FY24 guidance to the mid to high end for all metrics, indicating strong performance expectations.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:42 am

ELAN

Elanco Animal Health (NYSE:ELAN) reported Q2 2024 adjusted EPS of $0.30, beating the $0.24 estimate by 25%. Sales were $1.184 billion, surpassing the $1.156 billion estimate by 2.40%. This represents a 66.67% increase in EPS and a 12.02% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:41 am

AVAH

Aveanna Healthcare Holdings has updated its full-year 2024 guidance, expecting revenue to exceed $1.985 billion, up from the previous guidance of over $1.970 billion. Adjusted EBITDA is now expected to be greater than $158 million, up from the prior guidance of over $150 million.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:41 am

DCO

Ducommun (NYSE:DCO) reported Q2 2024 adjusted EPS of $0.83, beating the $0.60 estimate by 38.33%. Sales were $197M, surpassing the $194.567M estimate by 1.25%. This marks a 53.7% increase in EPS and a 5.17% rise in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:40 am

NUVL

Nuvalent reported a Q2 2024 GAAP EPS of $(0.88), missing the estimate of $(0.76).

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:40 am

FTCI

FTC Solar has announced its Q3 revenue guidance, expecting between $9.0 million and $11.0 million.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:37 am